Medications that increase the risk of PML include the following (in descending order of risk): Natalizumab Fingolimod Siponimod Rituximab Ocrelizumab Ofatumumab Rarely, dimethyl fumarate If any of these medications are used, consultation with a neurologist with training in MS is highly recommended.